Compositions and Methods For Treating Cancer With Anti-CD22 Immunotherapy
Technology
E-014-2018
Patent ID
E-014-2018-0-US-07
Country
US
Application Type
DIV
Patent Status
Issued
Patent Number
11878052
Publication Number
US-2020-0155661-A1
Application Number
16/773,379
IC
NCI
Date Filed
Date Issued